Importer of Controlled Substances; Notice of Registration, 19596 [E9-9784]
Download as PDF
<![CDATA[
19596
Federal Register / Vol. 74, No. 81 / Wednesday, April 29, 2009 / Notices
Dated: April 17, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E9–9795 Filed 4–28–09; 8:45 am]
Dated: April 17, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E9–9791 Filed 4–28–09; 8:45 am]
DEPARTMENT OF JUSTICE
BILLING CODE 4410–09–P
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration
Importer of Controlled Substances;
Notice of Registration
By Notice dated December 22, 2008,
and published in the Federal Register
on December 31, 2008 (73 FR 80431),
Johnson Matthey Inc., Pharmaceutical
Materials, 2003 Nolte Drive, West
Deptford, New Jersey 08066–1742, has
made application by letter to the Drug
Enforcement Administration (DEA) to
be registered as an importer of the basic
classes of controlled substances listed in
schedule II:
By Notice dated January 9, 2009, and
published in the Federal Register on
January 21, 2009 (74 FR 3642), Noramco
Inc., 1440 Olympic Drive, Athens,
Georgia 30601, made application by
letter to the Drug Enforcement
Administration (DEA) to be registered as
an importer of Thebaine (9333), a basic
class of controlled substance listed in
schedule II.
The company plans to import
analytical reference standards for
distribution to its customers for research
purposes.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
Noramco Inc. to import the basic class
of controlled substance is consistent
with the public interest, and with
United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971, at
this time. DEA has investigated
Noramco Inc. to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic class of controlled substance
listed.
By Notice dated February 5, 2009, and
published in the Federal Register on
February 11, 2009 (74 FR 6920), Roche
Diagnostics Operations Inc., Attn:
Regulatory Compliance, 9115 Hague
Road, Indianapolis, Indiana 46250,
made application by renewal to the
Drug Enforcement Administration
(DEA) to be registered as an importer of
the basic classes of controlled
substances listed in schedules I and II:
Drug
Schedule
pwalker on PROD1PC71 with NOTICES
Thebaine (9333) ...........................
Noroxymorphone (9668) ...............
II
II
The company plans to import
analytical reference standards for
distribution to its customers for research
purposes.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
Johnson Matthey Inc. to import the basic
classes of controlled substances is
consistent with the public interest, and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971, at
this time. DEA has investigated Johnson
Matthey Inc. to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic classes of controlled
substances listed.
Dated: April 17, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E9–9788 Filed 4–28–09; 8:45 am]
BILLING CODE 4410–09–P
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration
Drug
Lysergic acid diethylamide (7315)
Tetrahydrocannabinols (7370) .....
Alphamethadol (9605) ..................
Cocaine (9041) .............................
Ecgonine (9180) ...........................
Methadone (9250) ........................
Morphine (9300) ...........................
17:48 Apr 28, 2009
Jkt 217001
PO 00000
Frm 00112
Fmt 4703
Sfmt 4703
I
I
I
II
II
II
II
The company plans to import the
listed controlled substances for the
manufacture of diagnostic products for
distribution to its customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a),
and determined that the registration of
Roche Diagnostics Operations Inc. to
import the basic classes of controlled
substances is consistent with the public
interest, and with United States
obligations under international treaties,
conventions, or protocols in effect on
May 1, 1971, at this time. DEA has
investigated Roche Diagnostics
Operations Inc. to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic classes of controlled
substances listed.
Dated: April 17, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E9–9784 Filed 4–28–09; 8:45 am]
BILLING CODE 4410–09–P
VerDate Nov<24>2008
Schedule
E:\FR\FM\29APN1.SGM
29APN1
]]>Agencies
[Federal Register Volume 74, Number 81 (Wednesday, April 29, 2009)]
[Notices]
[Page 19596]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-9784]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Registration
By Notice dated February 5, 2009, and published in the Federal
Register on February 11, 2009 (74 FR 6920), Roche Diagnostics
Operations Inc., Attn: Regulatory Compliance, 9115 Hague Road,
Indianapolis, Indiana 46250, made application by renewal to the Drug
Enforcement Administration (DEA) to be registered as an importer of the
basic classes of controlled substances listed in schedules I and II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Lysergic acid diethylamide (7315).......... I
Tetrahydrocannabinols (7370)............... I
Alphamethadol (9605)....................... I
Cocaine (9041)............................. II
Ecgonine (9180)............................ II
Methadone (9250)........................... II
Morphine (9300)............................ II
------------------------------------------------------------------------
The company plans to import the listed controlled substances for
the manufacture of diagnostic products for distribution to its
customers.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and 952(a), and determined that the
registration of Roche Diagnostics Operations Inc. to import the basic
classes of controlled substances is consistent with the public
interest, and with United States obligations under international
treaties, conventions, or protocols in effect on May 1, 1971, at this
time. DEA has investigated Roche Diagnostics Operations Inc. to ensure
that the company's registration is consistent with the public interest.
The investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background and
history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in
accordance with 21 CFR 1301.34, the above named company is granted
registration as an importer of the basic classes of controlled
substances listed.
Dated: April 17, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E9-9784 Filed 4-28-09; 8:45 am]
BILLING CODE 4410-09-P
